Does DURVALUMAB Cause Hepatic function abnormal? 210 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 210 reports of Hepatic function abnormal have been filed in association with DURVALUMAB (IMFINZI). This represents 1.2% of all adverse event reports for DURVALUMAB.
210
Reports of Hepatic function abnormal with DURVALUMAB
1.2%
of all DURVALUMAB reports
28
Deaths
99
Hospitalizations
How Dangerous Is Hepatic function abnormal From DURVALUMAB?
Of the 210 reports, 28 (13.3%) resulted in death, 99 (47.1%) required hospitalization, and 25 (11.9%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DURVALUMAB. However, 210 reports have been filed with the FAERS database.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which DURVALUMAB Alternatives Have Lower Hepatic function abnormal Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE